Tag: PTCT

On January 27, 2024, Cantor Fitzgerald analyst Kristen Kluska expressed her positive outlook on PTC Therapeutics (NASDAQ: PTCT) by maintaining ...

On January 27, 2024, esteemed analyst Brian Abrahams from RBC Capital made a notable decision regarding PTC Therapeutics (NASDAQ: PTCT). ...

On January 26, 2024, PTC Therapeutics was hit with a major setback in Europe. The Committee for Medicinal Products for ...